Matches in Nanopublications for { ?s ?p "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP694324.RAXGrcslYQVDT2wHyNKcBMaOuKJD9-i0sUqiVU9_f-or0130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694324.RAXGrcslYQVDT2wHyNKcBMaOuKJD9-i0sUqiVU9_f-or0130_provenance.
- NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977729.RAlliaPQ7-fjzWhfzXaqmlDkl4DY2ir-aeXNMjkZgXDi4130_provenance.
- NP694323.RAMQDmAkTxqFBmZusciJDyfPb5u3TW75BhVp4zrBXUOo4130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694323.RAMQDmAkTxqFBmZusciJDyfPb5u3TW75BhVp4zrBXUOo4130_provenance.
- assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261792.RAs21ot1mfIqXSpon0nhXW4BBXVIfapFw1RRPRvw6CTPQ130_provenance.
- NP694322.RAlWqSOrYOhzrx4WKuxk8Mkx4Fx_E4xuJ_pIHvI-ennZQ130_assertion description "[In conclusion, the Bcl-2 inhibitor ABT-737 sensitized cancer cells to the antitumor effect of antigen-specific immunotherapy in a vaccine model for the CT26 colon carcinoma in vivo but not in two immunotherapy strategies against B16 melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694322.RAlWqSOrYOhzrx4WKuxk8Mkx4Fx_E4xuJ_pIHvI-ennZQ130_provenance.